Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials |
| BNF code | 1404000ALAAACAC |
| Virtual Therapeutic Moiety | Shingles (Herpes Zoster) vaccine |
| Abbreviated name | Shingles (Herpes Zoster) adjuvanted rcmb vacc inj 0.5ml |
| Basis of preferred name | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 0.500 |
| Unit dose form units | ml |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Varicella-Zoster surface antigens |
| Ontology Drug Form & Route | |
| Form & Route | suspensioninjection.intramuscular |
| Dose Form | |
| Formulation | Powder and suspension for suspension for injection |
| Drug Route | |
| Route | Intramuscular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Shingrix (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.